Similarly, a fisetin (a plant flavonoid) treatment suppresses HFD-induced steatosis by upregulating the HNF4α expression and reducing oxidative stress, which further protects the individual from NAFLD progression [24]. This evidence concerns the gene HNF4A and metabolic dysfunction-associated steatotic liver disease.